Understanding how a parasite-derived peptide prevents immune mediated demyelination

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1142006

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Over millennia of co-evolution with humans, parasitic worms have developed the capacity to modulate the human immune system. We have characterised and identified novel molecules secreted by these worms. In this project we will assess the therapeutic potential of the parasite molecules using animal models of relapsing remitting multiple sclerosis.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2020

Funding Scheme: Project Grants

Funding Amount: $496,978.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Parasitology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

helminth infection | inflammation | multiple sclerosis (MS) | peptides | therapy

Related Links